Skip to content

Total debt at other companies

Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$1.91M-44.3%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$85.16M-7.9%
3M logo
3MMMM
Biogen logo
BiogenBIIB
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
Entegris logo
EntegrisENTG

Other financials

Income statement

See full
Revenue$200.5M+5.2%
Gross profit$64.6M+13.3%
Operating income$10.7M+3,667%
Net income$4.5M+421%
EPS (diluted)$0.25+413%

Balance sheet

See full
Cash & equivalents$195.8M+11.5%
Total equity$1.2B-6.1%
Total assets$1.4B-5.6%

Cash flow

See full
Operating cash flow$5.8M-50.4%
CapEx$4.7M-51.0%
Free cash flow$1.1M-47.6%

Valuation

See full
Market cap$2.84B+53.1%
Enterprise value$2.67B+57.7%
P/S3.5×+1.2×

Profitability

See full
Gross margin32.2%-0.7pp
Operating margin8.1%-6.7pp
Net margin-7.4%-9.5pp
FCF margin8.5%+1.8pp

Returns & leverage

See full
Return on equity-4.9%-6.3pp
Debt / equity0.0×
Current ratio+0.1×

Where this comes from

Calculated from Rogers Corporation’s reported figures.

Plus components not separately reported this period.

The official record: Rogers Corporation’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rogers Corporation's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rogers Corporation's total debt?
Rogers Corporation (ROG) reported total debt of $29.8M in Q1 2026.
How has Rogers Corporation's total debt changed year-over-year?
Rogers Corporation's total debt decreased by 10.5% year-over-year, from $33.3M to $29.8M.
What is the long-term trend for Rogers Corporation's total debt?
Over 5 years (2020 to 2025), Rogers Corporation's total debt has grown at a -2.4% compound annual growth rate (CAGR), from $34.57M to $30.6M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.